| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.36 | 0.01 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |